Share

Testing of chemicals

Presentations from the OECD Industry Event, Multilateral Symposium between Monitoring Authorities, Regulatory Authorities and Test Facilities on the Implementation of the OECD Principles of GLP

 

 

  • Presentation 1 - Opening of the Event
  • Presentation 2 - Current State of implementation by Members and Non-Members of the OECD Council Decisions Related to MAD
    Presentation 3 - Quest for Harmonisation: Differences and Similarities in National Programmes for GLP Monitoring 
  • Presentation 4 - Future Issues including Broadening the Scope of the GLP Princilpes
  • Presentation 5 - OECD Principles of GLP: What is Working and What Needs Work
  • Presentation 6 - Implementation of OECD Principles in Test Facilities Complying with a Quality System Accredited to ISO/IEC 17025
  • Presentation 7a - Critical Aspects in Implementing the OECD Monograph 14 'The Application of the Principles of GLP to In-vitro Studies'
  • Presentation 7b - Critical Aspects in Implementing the OECD Monograph 14 'The Application of the Principles of GLP to In-vitro Studies'
  • Presentation 8 - Relationship between Receiving Authorities and Monitoring Authorities: The EMEA Experience
  • Presentation 9 - Collaboration between Monitoring Authorities, Regulatory Authorities and Test Facilities on GLP Principles
  • Presentation 10 - National GLP Programmes and Implication of Pharmaceuticals, Pesticides and Other Chemicals Regulatory Authorities in Japan
  • Presentation 11 - GLP 30 Years on: Challenges for Industry
  • Presentation 12 - Implementation of the OECD GLP Principles at Test Facilities in Japan
  • Presentation 13 - Risk based Assessment Applied to QA GLP Audits
  • Presentation 14 - Critical Aspects Regarding the Application of GLP Principles to New Compounds such as Biotechnology Products
  • Presentation 15a - GLP: Key Issues from the Point of View of a Test Facility
  • Presentation 15b - GLP: Key Issues from the Point of View of a Test Facility
  • Presentation 16 - Differences in the interpretation of the GLP Requirements by OECD Monitoring Authorities: The Point of View of the Pharmaceutical Industry
  • Presentation 17 - OECD and US GLP Applications
  • Presentation 18 - Responsibilities of Test Facility Management and Sponsor
  • Presentation 19 - Developments in GLP Consultation and Training 1980-2020

 

Related Documents